These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37727906)

  • 1. Remimazolam and serious adverse events: A scoping review.
    Kempenaers S; Hansen TG; Van de Velde M
    Eur J Anaesthesiol; 2023 Nov; 40(11):841-853. PubMed ID: 37727906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of propofol vs. remimazolam on emergence profiles after general anesthesia: A randomized clinical trial.
    Oh EJ; Chung YJ; Lee JH; Kwon EJ; Choi EA; On YK; Min JJ
    J Clin Anesth; 2023 Nov; 90():111223. PubMed ID: 37506483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy.
    Worthington MT; Antonik LJ; Goldwater DR; Lees JP; Wilhelm-Ogunbiyi K; Borkett KM; Mitchell MC
    Anesth Analg; 2013 Nov; 117(5):1093-100. PubMed ID: 24108261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term delayed emergence after remimazolam-based general anesthesia: a case report.
    Takemori T; Oyama Y; Makino T; Hidaka S; Kitano T
    JA Clin Rep; 2022 Oct; 8(1):86. PubMed ID: 36260199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Remimazolam in Endoscopic Sedation-A Systematic Review and Meta-Analysis.
    Zhu X; Wang H; Yuan S; Li Y; Jia Y; Zhang Z; Yan F; Wang Z
    Front Med (Lausanne); 2021; 8():655042. PubMed ID: 34381792
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remimazolam: An Updated Review of a New Sedative and Anaesthetic.
    Hu Q; Liu X; Wen C; Li D; Lei X
    Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.
    Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T
    Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Arrest Following Remimazolam-Induced Anaphylaxis: A Case Report.
    Hasushita Y; Nagao M; Miyazawa Y; Yunoki K; Mima H
    A A Pract; 2022 Sep; 16(9):e01616. PubMed ID: 36149988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of remimazolam and sedatives in the intensive care unit.
    Choi HR; Song IA
    Acute Crit Care; 2022 May; 37(2):151-158. PubMed ID: 35698764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures.
    Morimoto Y
    Ther Clin Risk Manag; 2022; 18():95-100. PubMed ID: 35140469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remimazolam: A Review in Procedural Sedation.
    Lee A; Shirley M
    Drugs; 2021 Jul; 81(10):1193-1201. PubMed ID: 34196946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anesthetic management of super-elderly patients with remimazolam: a report of two cases.
    Nakayama J; Ogihara T; Yajima R; Innami Y; Ouchi T
    JA Clin Rep; 2021 Sep; 7(1):71. PubMed ID: 34528145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of remimazolam and midazolam for the sedation of gastrointestinal endoscopy: a meta-analysis of randomized controlled studies.
    Zhang L; Li C; Zhao C; You Y; Xu J
    Afr Health Sci; 2022 Jun; 22(2):384-391. PubMed ID: 36407397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent.
    Kilpatrick GJ
    Front Pharmacol; 2021; 12():690875. PubMed ID: 34354587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitored Anesthesia Care Under a Combination of Low-Dose Remimazolam Infusion and Flumazenil Antagonism: A Case Report.
    Kamata K; Masui K
    Cureus; 2023 Oct; 15(10):e46728. PubMed ID: 38021893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remimazolam for sedation: A protocol for a systematic review with meta-analysis, trial sequential analysis, and GRADE approach.
    Stehr-Pingel L; Maagaard M; Tvarnø CD; Andersen LPK; Andersen JH; Mathiesen O
    Acta Anaesthesiol Scand; 2023 Nov; 67(10):1432-1438. PubMed ID: 37580880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.